Intravascular Stents Market Size & Growth Forecast 2027–2036, By Segments (Mode of Delivery, Type Scope, End Use Scope, Product Scope), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Intravascular Stents Market size was valued at USD 16.5 billion in 2026 and is projected to grow at a 7.6% CAGR from 2027 to 2036, reaching USD 34.32 billion by 2036. The industry revenue for 2027 is estimated at USD 17.56 billion.
Get more details on this report
Request Free Sample ReportIntravascular Stents Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 46.42% share due to high procedure volumes, advanced interventional cardiology access, and mature treatment pathways integrated across hospitals and cardiac centers.
- Asia Pacific is expanding at 9.15% CAGR, supported by improving treatment access, expanding cath lab infrastructure, and rising adoption of minimally invasive cardiovascular procedures.
Segment Momentum
- Balloon-expandable Stents accounted for 56.61% of the market in 2026 because their precise placement and controlled deployment make them well suited to routine vascular interventions and established clinical workflows.
- Bioabsorbable Stents are the fastest-growing type segment as interest increases in temporary scaffolding solutions that restore vessel function without leaving permanent metallic implants, supporting evolving treatment preferences.
Market Expansion Drivers
- Rising prevalence of cardiovascular diseases and aging population driving demand for minimally invasive vascular interventions.
- Advancements in drug-eluting and bioresorbable stent technologies improving long-term patient outcomes.
- Expansion of hospital catheterization lab infrastructure increasing procedural capacity for stent implantation.
Leading Market Participants
- Key players in the intravascular stents market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), Terumo Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Cook Medical LLC (United States), Cordis Corporation (United States), MicroPort Scientific Corporation (China), iVascular S.L.U. (Spain), Lifetech Scientific Corporation (China), Stryker Corporation (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 16.5 billion
- 2027 Estimated Market Size: USD 17.56 billion.
- Projected Market Size: USD 34.32 billion by 2036
- Growth Forecast: 7.6% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Balloon-expandable Stents (Mode of Delivery) | Drug Eluting Stents (DES) (Type Scope) | Hospitals & Cardiac Centers (End Use Scope) | Coronary Stents (Product Scope)
- Emerging Opportunity Segment: Self-expanding Stents (Mode of Delivery) | Bioabsorbable Stents (Type Scope) | Ambulatory Surgical Centers (End Use Scope) | Peripheral Stents (Product Scope)
Market Growth Drivers and Industry Trends
Rising prevalence of cardiovascular diseases and aging population driving demand for minimally invasive vascular interventions
The intravascular stents market is supported by the growing burden of cardiovascular diseases and the increasing number of older patients requiring vascular treatment. Minimally invasive stent-based procedures provide physicians with an established approach for restoring blood flow in narrowed or obstructed vessels while avoiding the greater tissue disruption associated with open surgery. As cardiovascular care increasingly emphasizes less invasive interventions, demand for stent systems capable of supporting complex vascular procedures is increasing across hospitals and specialized cardiovascular centers.
Advancements in drug-eluting and bioresorbable stent technologies improving long-term patient outcomes
Technological progress in stent design is improving treatment performance by addressing complications such as restenosis and the long-term presence of permanent implants. The intravascular stents market is benefiting from drug-eluting technologies that deliver therapeutic agents locally to help limit abnormal tissue growth following implantation, while bioresorbable approaches are being developed to provide temporary vascular support before gradually degrading. Improvements in stent coatings, materials, delivery systems, and drug-release characteristics are also giving clinicians more options for tailoring interventions to patient and lesion characteristics.
Expansion of hospital catheterization lab infrastructure increasing procedural capacity for stent implantation
Investment in catheterization laboratories is expanding the capacity of healthcare facilities to perform image-guided cardiovascular interventions and manage patients requiring vascular procedures. Within the intravascular stents market, greater availability of specialized facilities, imaging systems, and trained interventional teams supports increased access to stent implantation procedures. Hospitals are also strengthening procedural infrastructure to manage a wider range of cardiovascular cases, allowing minimally invasive interventions to be incorporated more extensively into routine cardiac and vascular care pathways.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of cardiovascular diseases and aging population driving demand for minimally invasive vascular interventions | 2.60% | High | North America, Asia Pacific | High | Near Term |
| Advancements in drug-eluting and bioresorbable stent technologies improving long-term patient outcomes | 2.20% | High | North America, Europe | High | Near Term |
| Expansion of hospital catheterization lab infrastructure increasing procedural capacity for stent implantation | 1.70% | High | Asia Pacific, Latin America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
Holding the largest share of the intravascular stents market, North America accounted for 46.42% in 2026, supported by a well-developed cardiovascular care infrastructure and broad access to advanced diagnostic and interventional procedures. The region's high adoption of minimally invasive treatment approaches, combined with strong clinical expertise and established hospital networks, supports the use of stent-based therapies. Continued attention to early diagnosis and management of cardiovascular conditions also contributes to procedure volumes. Favorable healthcare spending capacity, ongoing technological innovation, and the availability of specialized treatment facilities further reinforce North America's leading market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, benefiting from expanding healthcare infrastructure, increasing access to specialized cardiovascular treatment, and greater awareness of vascular disease management. Economic development in several markets is supporting investment in hospitals, catheterization laboratories, and advanced medical technologies. A growing patient population requiring cardiovascular interventions, together with improving diagnostic capabilities and broader adoption of minimally invasive procedures, is creating substantial demand potential. Government and private-sector efforts to strengthen healthcare delivery are also expected to support the continued expansion of the regional market.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Treatment FocusGermany emphasizes high-quality interventional cardiology supported by well-established hospital infrastructure. The intravascular stents market in Germany favors products that demonstrate procedural reliability, regulatory compliance, and compatibility with evolving minimally invasive treatment approaches.
France 🇫🇷
Evidence-Based ProcurementFrance places importance on clinically validated intravascular stents within structured healthcare purchasing processes. The market favors technologies supported by strong clinical evidence, encouraging manufacturers to emphasize long-term safety, effectiveness, and procedural consistency.
Italy 🇮🇹
Hospital Modernization DemandItaly continues to strengthen interventional cardiology capabilities through investments in hospital-based cardiovascular services. The intravascular stents market reflects demand for dependable products that support routine clinical practice while improving procedural outcomes across regional healthcare facilities.
Japan 🇯🇵
Advanced Device IntegrationJapan focuses on integrating technologically sophisticated intravascular stents into specialized cardiovascular treatment pathways. Japanese healthcare providers value durable device performance and evidence-based innovation that supports improved procedural efficiency and patient management.
South Korea 🇰🇷
Digital Cardiac CareSouth Korea combines advanced healthcare facilities with rapid adoption of innovative cardiovascular interventions. The country's intravascular stents market benefits from demand for modern devices that support precision treatment and efficient clinical workflows across specialized cardiac centers.
United States 🇺🇸
Clinical Innovation HubThe U.S. intravascular stents market is shaped by strong adoption of next-generation stent technologies supported by advanced cardiovascular care networks. Healthcare providers in the U.S. prioritize devices with proven long-term outcomes, creating opportunities for continuous product refinement and clinical differentiation.
Segment Leadership and Growth Trends
Intravascular Stents Market Share (%), by Mode of Delivery, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMode of Delivery Segment Analysis: Balloon-expandable Stents (Largest Segment) vs Self-expanding Stents (Fastest-Growing Segment)
The balloon-expandable stents segment held the largest share of the intravascular stents market, accounting for 56.61% in 2026, supported by their precise deployment characteristics and established use in lesions requiring accurate placement and controlled expansion. Their ability to achieve high radial force and predictable positioning has contributed to continued adoption in coronary and other vascular interventions, particularly where precise stent placement is clinically important.
Self-expanding stents are projected to register the fastest growth during the forecast period, driven by their flexibility and ability to conform to changing vessel anatomy. Their suitability for tortuous and peripheral vessels, combined with increasing demand for minimally invasive vascular procedures and stent technologies capable of accommodating complex anatomical conditions, is expected to strengthen adoption.
Type Scope Segment Analysis: Drug Eluting Stents (DES) (Largest Segment) vs Bioabsorbable Stents (Fastest-Growing Segment)
Drug eluting stents (DES) dominated the market with a 61.13% share in 2026, reflecting their established role in reducing restenosis through controlled drug delivery at the treatment site. Continued clinical preference for technologies that improve procedural outcomes, along with ongoing advancements in stent coatings and drug-release mechanisms, has reinforced the widespread use of DES in vascular interventions.
The bioabsorbable stents segment is expected to expand at the fastest pace during the forecast period as attention increasingly shifts toward vascular devices designed to provide temporary structural support before being naturally absorbed. Interest in reducing the long-term presence of permanent implants, together with continued innovation in biodegradable materials and device design, is supporting the development and adoption of these technologies.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Mode of Delivery | Self-expanding Stents, Balloon-expandable Stents | Balloon-expandable Stents | Self-expanding Stents |
| Type Scope | Drug Eluting Stents (DES), Bare Metal Stents (BMS), Bioabsorbable Stents | Drug Eluting Stents (DES) | Bioabsorbable Stents |
| End Use Scope | Hospitals & Cardiac Centers, Ambulatory Surgical Centers, Others | Hospitals & Cardiac Centers | Ambulatory Surgical Centers |
| Product Scope | Coronary Stents, Peripheral Stents, Neurovascular Stents | Coronary Stents | Peripheral Stents |
Competitive Landscape and Market Positioning
Top players in the intravascular stents market:
1. Medtronic plc (Ireland)
2. Boston Scientific Corporation (United States)
3. Terumo Corporation (Japan)
4. BIOTRONIK SE & Co. KG (Germany)
5. Cook Medical LLC (United States)
6. Cordis Corporation (United States)
7. MicroPort Scientific Corporation (China)
8. iVascular S.L.U. (Spain)
9. Lifetech Scientific Corporation (China)
10. Stryker Corporation (United States)
Medical innovation and clinical precision are driving advancements in the intravascular stents market, with emphasis on improved biocompatibility and enhanced delivery mechanisms. Ongoing research is focused on reducing procedural risks while improving long-term patient outcomes. The intravascular stents market is increasingly shaped by minimally invasive treatment advancements.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Terumo Corporation (Japan) | |||||||
| BIOTRONIK SE & Co. KG (Germany) | |||||||
| Cook Medical LLC (United States) | |||||||
| Cordis Corporation (United States) | |||||||
| MicroPort Scientific Corporation (China) | |||||||
| iVascular S.L.U. (Spain) | |||||||
| Lifetech Scientific Corporation (China) | |||||||
| Stryker Corporation (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Intravascular Stents Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Indication | Coronary Artery Disease, Peripheral Artery Disease, Carotid Artery Disease, Renal Artery Disease, Other Vascular Disorders |
| Procurement Channel | Direct Manufacturer Sales, Distributor & Wholesaler Sales, Group Purchasing Organizations, Government & Institutional Procurement |
| Lesion Complexity | Simple Lesions, Moderate-Complexity Lesions, Complex Lesions, Chronic Total Occlusions |
Intravascular Stents Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption Barrier Assessment |
|
| Next-Generation Stent Innovation Landscape |
|
| Reimbursement and Healthcare Economics Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the intravascular stents market?
What are the growth projections for the intravascular stents industry?
Why is demand for intravascular stents rising in modern cardiovascular care pathways?
How are stent technology advancements influencing hospital purchasing decisions?
Why are Balloon-expandable Stents the leading mode of delivery in the intravascular stents market?
What is the fastest-growing type segment in the intravascular stents market?
Why does North America hold the largest share of the intravascular stents market?
What is driving growth in the intravascular stents market across Asia Pacific?
Which companies are driving growth in the intravascular stents landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization